Nutriband, Inc. Stock Plummets to New 52-Week Low of $3.42

Nutriband, Inc., a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 3.42 on March 20, 2026. This significant decline highlights ongoing challenges within the company, which has been grappling with financial difficulties. With a market capitalization of USD 46 million, Nutriband's performance metrics reveal a concerning picture, including a negative return on equity of -121.64% and a price-to-book ratio of 6.13. The company has reported substantial losses, contributing to a lack of profitability reflected in its operating cash flow, which stands at a low of USD -5.64 million. Additionally, the rising raw material costs, which have increased by 35.83% year-over-year, further strain the company's financial health. Over the past year, Nutriband's stock has generated a return of -44.01%, indicating a significant underperformance compared to broader market indices. As the stock continues to trade at these low levels, it underscores the ongoing challenges faced by Nutriband in a competitive industry landscape.